Maropitant

CAS No. 147116-67-4

Maropitant( —— )

Catalog No. M20648 CAS No. 147116-67-4

Maropitant is a selective neurokinin (NK1) receptor antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
5MG 41 In Stock
10MG 69 In Stock
25MG 112 In Stock
50MG 207 In Stock
100MG 310 In Stock
200MG 445 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Maropitant
  • Note
    Research use only, not for human use.
  • Brief Description
    Maropitant is a selective neurokinin (NK1) receptor antagonist.
  • Description
    Maropitant is a selective neurokinin (NK1) receptor antagonist.
  • In Vitro
    ——
  • In Vivo
    Treatment with 1 mg/kg Maropitant citrate, significantly reduces the size of ulcerative dermatitis (UD) lesions in mice. Intravenous Maropitant decreases MAC by 16%. In contrast, epidural administration of either saline or Maropitant does not change the MAC (2.17% and 1.92 %, respectively).
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    NK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    147116-67-4
  • Formula Weight
    468.67
  • Molecular Formula
    C32H40N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:33.33 mg/mL (71.12 mM)
  • SMILES
    COc1ccc(cc1CN[C@H]1C2CCN(CC2)[C@H]1C(c1ccccc1)c1ccccc1)C(C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hickman M A Cox S R Mahabir S et al. Safety pharmacokinetics and use of the novel NK‐1 receptor antagonist maropitant (Cerenia TM ) for the prevention of emesis and motion sickness in cats[J]. Journal of Veterinary Pharmacology and Therapeutics 2008 31(3):220-229.
molnova catalog
related products
  • Neurokinin A(4-10)

    Neurokinin A (4-10) is a tachykinin NK2 receptor agonist. A structure-activity study of the neurokinin A (NKA) fragment NKA(4-10) was performed to investigate the importance of amino acid residues for receptor efficacy, potency and affinity at the NK2 receptor in human colon circular muscle.

  • Ezlopitant

    Ezlopitant (CJ-11974) is a small molecule neurokinin-1-receptor (NK1) antagonist used to treat nausea, vomiting and pain.

  • Vofopitant

    Vofopitant (GR 205171) is a potent NK1 receptor antagonist with anxiolytic and antiemetic activity for the study of post-traumatic stress disorder (PTSD).